How Can We Optimize the Value Assessment and Appraisal of Orphan Drugs for Reimbursement Purposes? A Qualitative Interview Study Across European Countries

Introduction: The expansion of orphan drug treatment at increasing prices, together with uncertainties regarding their (cost-)effectiveness raises difficulties for decision-makers to assess these drugs for reimbursement. The present qualitative study aims to gain better insight into current value as...

Descripción completa

Detalles Bibliográficos
Autores principales: Blonda, Alessandra, Denier, Yvonne, Huys, Isabelle, Kawalec, Pawel, Simoens, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343828/
https://www.ncbi.nlm.nih.gov/pubmed/35928274
http://dx.doi.org/10.3389/fphar.2022.902150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343828/
https://www.ncbi.nlm.nih.gov/pubmed/35928274
http://dx.doi.org/10.3389/fphar.2022.902150

Ejemplares similares